<i id='C429BE0FC4'><strike id='C429BE0FC4'><tt id='C429BE0FC4'><pre id='C429BE0FC4'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
United colonoscopy coverage change 'may cost lives,' doctors say 
Obesity now affects over 1 billion people worldwide, study finds 
ChatGPT in medicine: STAT answers readers' burning questions 
AstraZeneca loses challenge to Medicare drug price negotiation 
Hollywood unions extend contract negotiations for actors
AstraZeneca loses challenge to Medicare drug price negotiation 
23andMe had bad news about my health. I wish a person had delivered it 
RaDonda Vaught to speak at CommonSpirit event on patient safety 
Wildfire smoke exposes gaps in outdoor worker protections 
Abortion pill case raises question: who can sue the FDA? 
Activists slam private health insurers over coverage restrictions 
Eliminate the waiting period for sterilization covered by Medicaid 
As demand for Covid shots wanes, Moderna seeks its next success 
How to address the problem of discarded donor organs 
Psychedelics group wrestles with new pharma identity 
